Patel Y, Alsaedi H, Majd Z, Altaie I, Rahimi S, Fatima B
Patient Prefer Adherence. 2025; 19:473-484.
PMID: 40052001
PMC: 11882467.
DOI: 10.2147/PPA.S467892.
Chaudhri K, Liu H, Rodgers A, Day R, Atkins E, Gnanenthiran S
BMC Health Serv Res. 2025; 25(1):293.
PMID: 39984999
PMC: 11846346.
DOI: 10.1186/s12913-025-12391-8.
Navarro-Sabate A, Font R, Espinas J, Sola J, Martinez-Soler F, Gil-Gil M
Cancers (Basel). 2025; 17(2).
PMID: 39857981
PMC: 11763350.
DOI: 10.3390/cancers17020200.
Dragvoll I, Bofin A, Soiland H, Engstrom M
Breast J. 2025; 2024:7623194.
PMID: 39742356
PMC: 11142862.
DOI: 10.1155/2024/7623194.
Liquori G, Panattoni N, De Leo A, Dionisi S, Giannetta N, Gasperi B
Healthcare (Basel). 2024; 12(19).
PMID: 39408105
PMC: 11476112.
DOI: 10.3390/healthcare12191925.
Prevalence and Patient-Level Correlates of Intentional Non-Adherence to Immunosuppressive Medication After Heart-Transplantation-Findings From the International BRIGHT Study.
Marston M, Berben L, Dobbels F, Russell C, de Geest S
Transpl Int. 2023; 36:11308.
PMID: 37492859
PMC: 10363605.
DOI: 10.3389/ti.2023.11308.
Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review.
Yang S, Park S, Bae S, Ahn S, Jeong J, Park K
J Breast Cancer. 2023; 26(4):309-333.
PMID: 37272247
PMC: 10475712.
DOI: 10.4048/jbc.2023.26.e22.
Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach.
Green S, French D, Hall L, Bartlett Y, Rousseau N, Raine E
J Med Internet Res. 2023; 25:e38073.
PMID: 37223964
PMC: 10248768.
DOI: 10.2196/38073.
When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review.
Wreyford L, Gururajan R, Zhou X
PLoS One. 2023; 18(5):e0282180.
PMID: 37134109
PMC: 10155980.
DOI: 10.1371/journal.pone.0282180.
Adherence to oral anticancer hormonal therapy in breast cancer patients and its relationship with treatment satisfaction: an important insight from a developing country.
Koni A, Suwan B, Nazzal M, Sleem A, Daifallah A, Hamed Allah M
BMC Womens Health. 2023; 23(1):114.
PMID: 36941628
PMC: 10026465.
DOI: 10.1186/s12905-023-02276-5.
Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial.
Smith S, Green S, Ellison R, Foy R, Graham C, Mason E
BMJ Open. 2023; 13(2):e069971.
PMID: 36737093
PMC: 9900066.
DOI: 10.1136/bmjopen-2022-069971.
Characterizing factors influencing adherence to surgery and chemotherapy amongst women suffering from breast cancer in Mbingo Baptist Hospital Cameroon.
Nkenu N, Nsoh M, Jean Paul A, Nkondjock A
Pan Afr Med J. 2023; 43:102.
PMID: 36699974
PMC: 9834800.
DOI: 10.11604/pamj.2022.43.102.28672.
Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer.
Dragvoll I, Bofin A, Soiland H, Taraldsen G, Engstrom M
BMC Cancer. 2022; 22(1):1247.
PMID: 36456972
PMC: 9716686.
DOI: 10.1186/s12885-022-10362-4.
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
Jackson C, Finikarides L, Freeman A
PLoS One. 2022; 17(12):e0275321.
PMID: 36454979
PMC: 9714930.
DOI: 10.1371/journal.pone.0275321.
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.
Gil-Guillen V, Balsa A, Bernardez B, Valdes Y Llorca C, Marquez-Contreras E, de la Haba-Rodriguez J
Int J Environ Res Public Health. 2022; 19(19).
PMID: 36231341
PMC: 9564665.
DOI: 10.3390/ijerph191912036.
Intentional- but not Unintentional Medication Non-adherence was Related with Beliefs about Medicines Among a Multi-Ethnic Sample of People with HIV.
Castelan A, Nellen J, Van Der Valk M, Nieuwkerk P
AIDS Behav. 2022; 27(4):1045-1054.
PMID: 36056998
PMC: 9440648.
DOI: 10.1007/s10461-022-03842-y.
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.
Green S, French D, Graham C, Hall L, Rousseau N, Foy R
BMC Health Serv Res. 2022; 22(1):1081.
PMID: 36002831
PMC: 9404670.
DOI: 10.1186/s12913-022-08243-4.
Long-Term Adherence to Levothyroxine Replacement Therapy in Thyroidectomized Patients.
Bocale R, Desideri G, Barini A, DAmore A, Boscherini M, Necozione S
J Clin Med. 2022; 11(15).
PMID: 35893387
PMC: 9332058.
DOI: 10.3390/jcm11154296.
Exploring the influence of a user-specific explainable virtual advisor on health behaviour change intentions.
Abdulrahman A, Richards D, Bilgin A
Auton Agent Multi Agent Syst. 2022; 36(1):25.
PMID: 35401031
PMC: 8977831.
DOI: 10.1007/s10458-022-09553-x.
Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial.
Smith S, Ellison R, Hall L, Clark J, Hartley S, Mason E
Pilot Feasibility Stud. 2022; 8(1):33.
PMID: 35135619
PMC: 8822728.
DOI: 10.1186/s40814-022-00985-6.